Results
71,130 records
Include
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 9 | van Houte HansChief Financial Officer |  NRIXNurix Therapeutics, Inc.Option exercise | M | — 3,750 sh | Nov 2, 2026 |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 9 | van Houte HansChief Financial Officer | NRIXNurix Therapeutics, Inc. Option exercise | M | — 3,750 sh | Nov 2, 2026 |
| 9 | Hackman Jeffrey S.Director, Chief Executive Officer |  FENCFENNEC PHARMACEUTICALS INC.Grant or award | A | — 1,159 sh | Nov 2, 2026 traded Oct 31, 2026 |
| 9 | Barnes Victor ChristopherDirector |  SHENSHENANDOAH TELECOMMUNICATIONS CO/VA/Grant or award | A | $817 80 sh | Nov 2, 2026 traded Nov 2, 2026 |
| 9 | Gahan Patrick JosephDirector |  QMLSQumulusAI, Inc.Option exercise | M | — 182 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 9 | Krosnowski Scott CarrollChief Financial Officer | QMLSQumulusAI, Inc. Option exercise | M | — 33.3K sh | Nov 2, 2026 traded Oct 30, 2026 |
| 9 | van Houte HansChief Financial Officer | NRIXNurix Therapeutics, Inc. Option exercise | M | — 3,573 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 9 | Gahan Patrick JosephDirector | QMLSQumulusAI, Inc. Option exercise | M | $601 182 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 9 | Xu ShanshanDirector, See remarks, 10% Owner |  BBTXBambusa Therapeutics, Inc.Derivative conversion | C | — 15.8K sh | Nov 2, 2026 traded Nov 2, 2026 |
| 9 | Xu ShanshanDirector, See remarks, 10% Owner | BBTXBambusa Therapeutics, Inc. Derivative conversion | C | — 94.0K sh | Nov 2, 2026 traded Nov 2, 2026 |
| 9 | van Houte HansChief Financial Officer | NRIXNurix Therapeutics, Inc. Option exercise | M | — 3,573 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 9 | Mottola FrankSVP, Chief Tech. Ops. Officer |  SUPNSUPERNUS PHARMACEUTICALS, INC.Grant or award | A | — 100.0K sh | Nov 2, 2026 traded Oct 30, 2026 |
| 9 | Mulhall Christopher M.VP - Chief Accounting Officer |  FTVFortive CorpOption exercise | M | — 1,017 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 9 | Schwartz Barry PaulDirector | QMLSQumulusAI, Inc. Option exercise | M | $331 479 sh | Nov 2, 2026 traded Nov 2, 2026 |
| 9 | Mulhall Christopher M.VP - Chief Accounting Officer | FTVFortive Corp Option exercise | M | — 5,504 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 9 | Quaglio Kenneth LDirector | SHENSHENANDOAH TELECOMMUNICATIONS CO/VA/ Grant or award | A | $1,000 98 sh | Nov 2, 2026 traded Nov 2, 2026 |
| 9 | Wilson DarrenEVP & Pres, Retail & Payments |  VYXNCR Voyix CorpOption exercise | M | — 19.6K sh | Nov 2, 2026 traded Nov 1, 2026 |
| 9 | Reed John PDirector, CEO and Chairman, 10% Owner |  ARHSArhaus, Inc.Derivative conversion | C | — 222.2K sh | Nov 2, 2026 traded Oct 29, 2026 |
| 9 | Alfonso EduardoDirector |  BLCOBausch & Lomb CorpGrant or award | A | $23K 1,125 sh | Nov 2, 2026 traded Oct 29, 2026 |
| 9 | Xu ShanshanDirector, See remarks, 10% Owner | BBTXBambusa Therapeutics, Inc. Derivative conversion | C | — 4,155 sh | Nov 2, 2026 traded Nov 2, 2026 |
| 9 | Gahan Patrick JosephDirector | QMLSQumulusAI, Inc. Option exercise | M | — 11.4K sh | Nov 2, 2026 traded Oct 30, 2026 |
| 9 | Krosnowski Scott CarrollChief Financial Officer | QMLSQumulusAI, Inc. Option exercise | M | — 50.7K sh | Nov 2, 2026 traded Oct 30, 2026 |
| 9 | Gahan Patrick JosephDirector | QMLSQumulusAI, Inc. Option exercise | M | $601 182 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 9 | Gahan Patrick JosephDirector | QMLSQumulusAI, Inc. Option exercise | M | $34K 11.4K sh | Nov 2, 2026 traded Oct 30, 2026 |
| 9 | Xu ShanshanDirector, See remarks, 10% Owner | BBTXBambusa Therapeutics, Inc. Derivative conversion | C | — 1,753 sh | Nov 2, 2026 traded Nov 2, 2026 |
| 9 | Gahan Patrick JosephDirector | QMLSQumulusAI, Inc. Option exercise | M | — 182 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 9 | DiCiollo Anthony JHead of Institutional Segment |  SNEXStoneX Group Inc.Grant or award | A | — 6,604 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 9 | Salvia Investment GmbH10% Owner | BBTXBambusa Therapeutics, Inc. Derivative conversion | C | — 1.47M sh | Nov 2, 2026 traded Nov 2, 2026 |
| 9 | Xu ShanshanDirector, See remarks, 10% Owner | BBTXBambusa Therapeutics, Inc. Derivative conversion | C | — 10.4K sh | Nov 2, 2026 traded Nov 2, 2026 |
| 9 | Krosnowski Scott CarrollChief Financial Officer | QMLSQumulusAI, Inc. Option exercise | M | — 4,740 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 9 | Boattini JenniferSR VP Legal/General Counsel |  JBHTHUNT J B TRANSPORT SERVICES INCOption exercise | M | — 528 sh | Nov 2, 2026 traded Oct 31, 2026 |
| 9 | Guerre Robert PaulCorp. Sec, Dir Corp Compliance |  UFPIUFP INDUSTRIES INCGrant or award | A | $1,393 17 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 9 | Salvia Investment GmbH10% Owner | BBTXBambusa Therapeutics, Inc. Derivative conversion | C | — 3.14M sh | Nov 2, 2026 traded Nov 2, 2026 |
| 9 | Krosnowski Scott CarrollChief Financial Officer | QMLSQumulusAI, Inc. Option exercise | M | $14K 4,740 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 9 | Cioffi Christiana MarieChief Strategy Officer | FENCFENNEC PHARMACEUTICALS INC. Grant or award | A | — 156 sh | Nov 2, 2026 traded Oct 31, 2026 |
| 9 | Evans Terry LChief Commercial Officer | FENCFENNEC PHARMACEUTICALS INC. Grant or award | A | — 168 sh | Nov 2, 2026 traded Oct 31, 2026 |
| 9 | Woodruff Ronald GreerEVP Safety, ESG, Maintenance | JBHTHUNT J B TRANSPORT SERVICES INC Option exercise | M | — 230 sh | Nov 2, 2026 traded Oct 31, 2026 |
| 9 | Schultz Leigh AnnDirector | SHENSHENANDOAH TELECOMMUNICATIONS CO/VA/ Grant or award | A | $667 66 sh | Nov 2, 2026 traded Nov 2, 2026 |
| 9 | Boattini JenniferSR VP Legal/General Counsel | JBHTHUNT J B TRANSPORT SERVICES INC Tax withholding | F | $43K 196 sh | Nov 2, 2026 traded Oct 31, 2026 |
| 9 | Boattini JenniferSR VP Legal/General Counsel | JBHTHUNT J B TRANSPORT SERVICES INC Tax withholding | F | $40K 180 sh | Nov 2, 2026 traded Oct 31, 2026 |
| 9 | Boattini JenniferSR VP Legal/General Counsel | JBHTHUNT J B TRANSPORT SERVICES INC Option exercise | M | — 427 sh | Nov 2, 2026 traded Oct 31, 2026 |